SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Organovo Holdings, Inc. – ‘10-Q’ for 6/30/13 – ‘R30’

On:  Friday, 8/9/13, at 5:20pm ET   ·   For:  6/30/13   ·   Accession #:  1193125-13-329393   ·   File #:  1-35996

Previous ‘10-Q’:  ‘10-Q’ on 11/14/12 for 9/30/12   ·   Next:  ‘10-Q’ on 11/8/13 for 9/30/13   ·   Latest:  ‘10-Q’ on 2/8/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/09/13  Organovo Holdings, Inc.           10-Q        6/30/13   79:9.3M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    413K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
 4: EX-32.1     Exhiibt 32.1                                        HTML     23K 
77: R1          Document and Entity Information                     HTML     42K 
48: R2          Condensed Consolidated Balance Sheets               HTML    104K 
44: R3          Condensed Consolidated Balance Sheets               HTML     34K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML     75K 
                (Unaudited)                                                      
47: R5          Condensed Consolidated Statements of Stockholders'  HTML    125K 
                Equity (Deficit) (Unaudited)                                     
28: R6          Condensed Consolidated Statements of Cash Flows     HTML    128K 
                (Unaudited)                                                      
65: R7          Condensed Consolidated Statements of Cash Flows     HTML     45K 
                (Unaudited) (Parenthetical)                                      
29: R8          Change in Fiscal Year End                           HTML     25K 
34: R9          Description of Business and Summary of Significant  HTML     94K 
                Accounting Policies                                              
15: R10         Derivative Liability                                HTML     46K 
31: R11         Stockholders' Equity                                HTML     96K 
64: R12         Commitments and Contingencies                       HTML     44K 
59: R13         Concentrations                                      HTML     28K 
45: R14         Subsequent Events                                   HTML     33K 
72: R15         Description of Business and Summary of Significant  HTML    170K 
                Accounting Policies (Policies)                                   
62: R16         Description of Business and Summary of Significant  HTML     48K 
                Accounting Policies (Tables)                                     
13: R17         Derivative Liability (Tables)                       HTML     38K 
18: R18         Stockholders' Equity (Tables)                       HTML     86K 
71: R19         Commitments and Contingencies (Tables)              HTML     30K 
76: R20         Description of Business and Summary of Significant  HTML     33K 
                Accounting Policies (Details)                                    
78: R21         Description of Business and Summary of Significant  HTML     38K 
                Accounting Policies (Details 1)                                  
74: R22         Description of Business and Summary of Significant  HTML    240K 
                Accounting Policies (Details Textual)                            
56: R23         Derivative Liability (Details)                      HTML     36K 
16: R24         Derivative Liability (Details Textual)              HTML     44K 
27: R25         Stockholders' Equity (Details)                      HTML     34K 
22: R26         Stockholders' Equity (Details 1)                    HTML     58K 
21: R27         Stockholders' Equity (Details 2)                    HTML     36K 
35: R28         Stockholders' Equity (Details 3)                    HTML     50K 
55: R29         Stockholders' Equity (Details 4)                    HTML     27K 
61: R30         Stockholders' Equity (Details Textual)              HTML    273K 
24: R31         Commitments and Contingencies (Details)             HTML     35K 
36: R32         Commitments and Contingencies (Details Textual)     HTML     31K 
68: R33         Subsequent Events (Details Textual)                 HTML     66K 
43: XML         IDEA XML File -- Filing Summary                      XML     90K 
79: XML.R1      Document and Entity Information                      XML    121K 
33: XML.R2      Condensed Consolidated Balance Sheets                XML    279K 
54: XML.R3      Condensed Consolidated Balance Sheets                XML     89K 
                (Parenthetical)                                                  
42: XML.R4      Condensed Consolidated Statements of Operations      XML    294K 
                (Unaudited)                                                      
39: XML.R5      Condensed Consolidated Statements of Stockholders'   XML   1.71M 
                Equity (Deficit) (Unaudited)                                     
12: XML.R6      Condensed Consolidated Statements of Cash Flows      XML    504K 
                (Unaudited)                                                      
49: XML.R7      Condensed Consolidated Statements of Cash Flows      XML    142K 
                (Unaudited) (Parenthetical)                                      
11: XML.R8      Change in Fiscal Year End                            XML     40K 
25: XML.R9      Description of Business and Summary of Significant   XML    102K 
                Accounting Policies                                              
38: XML.R10     Derivative Liability                                 XML     58K 
30: XML.R11     Stockholders' Equity                                 XML    115K 
26: XML.R12     Commitments and Contingencies                        XML     54K 
66: XML.R13     Concentrations                                       XML     41K 
32: XML.R14     Subsequent Events                                    XML     44K 
75: XML.R15     Description of Business and Summary of Significant   XML    266K 
                Accounting Policies (Policies)                                   
51: XML.R16     Description of Business and Summary of Significant   XML     70K 
                Accounting Policies (Tables)                                     
50: XML.R17     Derivative Liability (Tables)                        XML     53K 
53: XML.R18     Stockholders' Equity (Tables)                        XML    127K 
23: XML.R19     Commitments and Contingencies (Tables)               XML     45K 
46: XML.R20     Description of Business and Summary of Significant   XML    304K 
                Accounting Policies (Details)                                    
60: XML.R21     Description of Business and Summary of Significant   XML    187K 
                Accounting Policies (Details 1)                                  
63: XML.R22     Description of Business and Summary of Significant   XML   4.68M 
                Accounting Policies (Details Textual)                            
67: XML.R23     Derivative Liability (Details)                       XML    155K 
37: XML.R24     Derivative Liability (Details Textual)               XML    258K 
20: XML.R25     Stockholders' Equity (Details)                       XML    101K 
69: XML.R26     Stockholders' Equity (Details 1)                     XML    221K 
52: XML.R27     Stockholders' Equity (Details 2)                     XML     90K 
70: XML.R28     Stockholders' Equity (Details 3)                     XML    297K 
17: XML.R29     Stockholders' Equity (Details 4)                     XML    124K 
58: XML.R30     Stockholders' Equity (Details Textual)               XML   6.50M 
57: XML.R31     Commitments and Contingencies (Details)              XML     73K 
19: XML.R32     Commitments and Contingencies (Details Textual)      XML     94K 
73: XML.R33     Subsequent Events (Details Textual)                  XML    658K 
40: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    716K 
 5: EX-101.INS  XBRL Instance -- onvo-20130630                       XML    957K 
 7: EX-101.CAL  XBRL Calculations -- onvo-20130630_cal               XML    139K 
 8: EX-101.DEF  XBRL Definitions -- onvo-20130630_def                XML    436K 
 9: EX-101.LAB  XBRL Labels -- onvo-20130630_lab                     XML    990K 
10: EX-101.PRE  XBRL Presentations -- onvo-20130630_pre              XML    714K 
 6: EX-101.SCH  XBRL Schema -- onvo-20130630                         XSD    147K 
41: ZIP         XBRL Zipped Folder -- 0001193125-13-329393-xbrl      Zip    118K 


‘R30’   —   Stockholders’ Equity (Details Textual)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v2.4.0.8
Stockholders' Equity (Details Textual) (USD $)
1 Months Ended 3 Months Ended 12 Months Ended 74 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 48 Months Ended 74 Months Ended 3 Months Ended 74 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 48 Months Ended 3 Months Ended 3 Months Ended 48 Months Ended 3 Months Ended
Agreements
Maximum [Member]
Maximum [Member]
Minimum [Member]
Minimum [Member]
Restricted Stock Units (RSUs) [Member]
Warrant [Member]
Warrant [Member]
Warrant [Member]
Warrant [Member]
Warrant [Member]
Maximum [Member]
Warrant [Member]
Minimum [Member]
Restricted Stock [Member]
Restricted Stock [Member]
Restricted Stock [Member]
Restricted Stock [Member]
Restricted Stock [Member]
Stock Options [Member]
Stock Options [Member]
Stock Options [Member]
Performance Based Restricted Stock Units (RSUs) [Member]
Equity Incentive Plan 2008 [Member]
Equity Incentive Plan 2008 [Member]
Equity Incentive Plan 2008 [Member]
Equity Incentive Plan 2008 [Member]
Equity Incentive Plan 2008 [Member]
Equity Incentive Plan 2012 [Member]
2012 Plan [Member]
2012 Plan [Member]
2012 Plan [Member]
Stock Options [Member]
2008 Plan [Member]
2008 Plan [Member]
2008 Plan [Member]
Stock Options [Member]
2008 Plan [Member]
Stock Options [Member]
Other Plan [Member]
Restricted Stock [Member]
General and Administrative Expense [Member]
General and Administrative Expense [Member]
General and Administrative Expense [Member]
Stock Options [Member]
General and Administrative Expense [Member]
Stock Options [Member]
Research and Development Expense [Member]
Research and Development Expense [Member]
Research and Development Expense [Member]
Stock Options [Member]
Research and Development Expense [Member]
Stock Options [Member]
Stockholders' Equity (Textual) [Abstract]                                                                                                    
Restricted common stock to founders                                             1,258,934                 1,086,662                   172,272                
Restricted stock vesting conditions                                                                         A quarter of which will vest on either the one year anniversary of employment or the one year anniversary of the vesting commencement date     A quarter of which will vest on the one year anniversary of employment, in May 2012, and the remaining options are vesting ratably over the remaining 36 month term                    
Stock Option Granted, Quarterly Vesting Restricted Term                                                                     3 years                              
Common shares authorized to be issued   7,450,242         7,450,242                                                   1,521,584 6,553,986                                
Shares issued during the year                                                         0   0                                      
Termination date of Equity Incentive Plan                                                           Jul. 01, 2018                                        
Termination date of Equity Incentive Plan, Description     10 years                                                                                              
Stock options granted under 2008 equity incentive plan   97,000 927,981   2,023,394                        21,997,182     60,000 55,000             950,000                                            
Percentage of vesting schedule                         25.00%                                                                          
Period for vesting schedule over start date                         4 years                                                                          
Restricted stock cancelled      34,690   185,516                                 58,342                                                        
Unrecognized stock-based compensation expense                                       $ 1,161,000       $ 1,161,000                                                    
Equity Incentive Plan, shares   896,256         896,256                                                                   896,256                  
Remaining options vest                                                                           36 months                        
Issuances of Common stock from stock option exercises, Shares          224,064                 252,129 7,090,556   13,532,487                                   51,500 305,658                            
Total employee stock-based compensation recorded as operating expenses                                       402,000   190   1,723,000 400,000 39,000 1,379,000                               398,000 140 333,000 4,000 4,000 50 67,000 35,000
Research and development expenses   1,462,000   653,000     9,544,000                                                                                      
General and administrative expense   2,378,000   1,056,000     14,917,000                                                                                      
Restricted stock forfeitures, shares                                                                                                     
Stock Option Granted, Restricted portion                                                                     45,500                              
Unrecognized stock-based compensation expense recognition maximum weighted average period                                       2 years 2 months 1 day                                                            
Granted incentive stock options to purchase shares of Common stock, exercise price                                                                             $ 0.08                      
Total unrecognized compensation cost related to unvested stock option grants, weighted average period                                                 3 years 3 months 18 days                                                  
Estimated fair value of warrants                                 889,000                                                                  
Life of warrants                 5 years   2 years                                                                              
Volatility rate   86.90%   95.77%                           103.80% 79.80%                                                              
Risk free factor   1.04%   1.21%                           0.63% 0.24%                                                              
Warrants exercisable price, per share 1.00       1.00         3.24   0.85       1   3.24 1.70                                                              
Exercise price of warrants before amendment               1.00                                                                                    
Exercise price of warrants after amendment               0.85                                                                                    
Number of agreement with consultants         4                                                                                          
Number of warrant exercised   252,129   145,000                       100,000                                                                    
Proceeds from warrant exercise   23,000,000                           100,000                                                                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                                                                                    
Issuance restricted Common stock to certain employees, advisors and consultants   60,000 55,000   1,380,000               230,000                                                                          
Weighted average remaining contractual term of options exercisable   8 years 8 months 16 days                       3 years 3 months 29 days                                                                        
Interest Expense   13,000         3,484,000             12,000                                                                        
Stockholders' Equity (Additional Textual) [Abstract]                                                                                                    
Restricted stock Issued       0                                                                                            
Number of shares issuable upon exercise of warrant   200,135   137,584     200,135                                                                                      
Weighted average remaining contractual term of options outstanding   9 years 5 months 9 days                                                                                                
Total unrecognized compensation cost related to unvested stock option grants   4,816,000         4,816,000                                                                                      
Cashless exercise for issuance of common stock   200,135   37,584     200,135                                                                                      
Outstanding warrants to purchase         14,500,000                                                                                          
Exercise price of warrant Amended 0.80       0.80                                                                                          
Warrant proceeds         9,600,000                                                                                          
Aggregate proceeds of Warrants tendered 7,700,000           32,743,000                                                                                      
Recognized expenses of warrants         1,900,000                                                                                          
Proceeds received from exercise of warrants         400,000                                                                                          
Number of warrant exercised through cashless   252,129   45,000                                                                                            
Price earned period         6 months                                                                                          
Recognized expenses of warrants   72,000         889,000                                                                                      
Warrants liability   129,000   874,000                                                                                            
Number of warrant exercised during period recorded as derivative liability   35,000   145,000                                                                                            
Warrants reclassified to additional paid in capital   767,000     890,000 1,111,000                                                                                        
Warrants reclassified to additional paid in capital   76,979,000 75,269,000       76,979,000                                                                                      
Research and development expenses   1,462,000   653,000     9,544,000                                                                                      
General and administrative expense   $ 2,378,000   $ 1,056,000     $ 14,917,000                                                                                      
Warrants to purchase common stock 650,000       650,000     269,657                                                                                    

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
7/1/18
Filed on:8/9/13
For Period end:6/30/13
4/30/13
3/31/1310-KT,  8-K
12/31/1210-K
6/30/1210-Q
1/31/128-K
12/31/1110-Q
10/12/11
5/31/08
 List all Filings 
Top
Filing Submission 0001193125-13-329393   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 6:58:18.1am ET